Sign in
4

Changes in Ownership

Edgewise Therapeutics, Inc. Filed Acc 0001562180-21-006455

Chief Scientific Officer sold 1,270 shares at $18.02 ($22,885)

From the SEC's structured data for this filing

Trades in this filing

Russell Alan J · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-10-11 Sale : show line 1 in the form −1,270 $18.02 $22,885 151,024 D
Open-market sales · 1,270 sh · avg $18.02 · $22,885
Loading xslF345X03/primarydocument.xml…